Showing results (1031-1040 of 1,510) with videos related to

Sort By:
Pageof 151
Virchows Archiv : an International Journal of Pathology|August 9, 2007
Hereditary neuroendocrine tumors of the gastroenteropancreatic systemMartin Anlauf, Nele Garbrecht, Juliane Bauersfeld, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 30, 2008
A new potent secondary amphipathic cell-penetrating peptide for siRNA delivery into mammalian cellsLaurence Crombez, Gudrun Aldrian-Herrada, Karidia Konate, et al.
Scientific Reports|December 2, 2016
Evidence of genotypic adaptation to the exposure to volcanic risk at the dopamine receptor DRD4 locusCharlotte Faurie, Clement Mettling, Mohamed Ali Bchir, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 1, 2012
Homologous mechanisms of visuospatial working memory maintenance in macaque and human: properties and sourcesRobert M G Reinhart, Richard P Heitz, Braden A Purcell, et al.
Pain Practice : the Official Journal of World Institute of Pain|March 19, 2016
Test-retest Reliability in Reporting the Pain Induced by a Pain Provocation Test: Further Validation of a Novel Approach for Pain Drawing Acquisition and AnalysisDiego Leoni, Deborah Falla, Carolin Heitz, et al.
Biochemical and Biophysical Research Communications|March 17, 2006
PIN-bodies: a new class of antibody-like proteins with CD4 specificity derived from the protein inhibitor of neuronal nitric oxide synthaseCédric Bès, Samuel Troadec, Myriam Chentouf, et al.
Bioorganic & Medicinal Chemistry Letters|September 3, 2003
1-Benzyloxy-4,5-dihydro-1H-imidazol-2-yl-amines, a novel class of NR1/2B subtype selective NMDA receptor antagonistsAlexander Alanine, Anne Bourson, Bernd Büttelmann, et al.
Bioorganic & Medicinal Chemistry Letters|March 6, 2003
2-(3,4-Dihydro-1H-isoquinolin-2yl)-pyridines as a novel class of NR1/2B subtype selective NMDA receptor antagonistsBernd Büttelmann, Alexander Alanine, Anne Bourson, et al.
Pageof 151